LTS Lohmann Therapie-Systeme competitors

LTS Lohmann Therapie-Systeme Competitors include Teva Pharmaceuticals, Omeros, CuraSen Therapeutics and Tarveda Therapeutics.
Add company...
LTS Lohmann Therapie-Systeme
LTS Lohmann Therapie-Systeme
LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.
Teva Pharmaceuticals
Teva Pharmaceuticals
Teva Pharmaceutical operates as a pharmaceutical company.
Omeros
Omeros
Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
CuraSen Therapeutics
CuraSen Therapeutics
CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases.
Tarveda Therapeutics
Tarveda Therapeutics
Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors.
Founding Date
Founding Date
1984
Founding Date
1901
Founding Date
1994
Founding Date
2016
Founding Date
2011
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Andernach, DE HQ
Shanghai, CN
West Caldwell, US
Locations
Petah Tikva, IL HQ
Villa Adelina, AR
Macquarie Park, AU
Bakı, AZ
Minsk, BY
Mirabel, CA
see more
Locations
Seattle, US HQ
Locations
HQ
Locations
Watertown, US HQ
Employees
Employees
N/A
Employees
51,792
Employees
173
Employees
6
Employees
284% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
17.8 b
Valuation ($)
827.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
2.8 k
Twitter followers
80
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$18.9b (FY, 2018)
Revenue (est.)
$29.9m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$10.6b (FY, 2018)
Cost of goods
$512k (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$8.3b (FY, 2018)
Gross profit
$29.4m (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
($2.5b) (FY, 2018)
Net income
($126.8m) (FY, 2018)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 54.5m (5 months ago)
Latest funding round
$ 30m (about 2 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 358m
Total funding raised
$ 354.8m
Total funding raised
$ 54.5m
Total funding raised
$ 158.6m
For sources of this data, please see the company profileDownload Excel

View company profiles

Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
51,792

Teva Pharmaceutical operates as a pharmaceutical company.

View company
Omeros
HQ
Seattle, US
Employees
173

Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.

View company
CuraSen Therapeutics
HQ
Employees
6

CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases.

View company
Tarveda Therapeutics
HQ
Watertown, US
Employees
28↑ 4% increase

Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors.

View company